San Diego, United States
Discover Echo Inc. has emerged as an innovator in the field of microscopy, reimagining traditional designs with its unique hybrid microscopes. Founded in 2013, the company leads with the world’s first and only microscopes capable of converting between both upright and inverted configurations.
Operating within the Biopharma, Biotechnology, Life Sciences, and Medical Devices industries, Discover Echo's extensive portfolio includes brightfield, fluorescence, live cell imaging, and confocal microscopy. Their award-winning devices promise precision and affordability, addressing a critical need for cost-effective solutions in scientific research.
The company emphasizes transparency with a straightforward online configuration and pricing tool. They also offer in-person and virtual demonstrations, further enhancing customer engagement and satisfaction.
Headquartered in the United States, Discover Echo received their last investment, a Series A, on March 17, 2020. Their approach balances innovation with strategic pricing, positioning them as a compelling opportunity for investors eyeing advancements in scientific tools and medical devices.
ONI
Ginkgo Bioworks
